Nxu, INC

Nxu, Inc. announced the termination of its merger agreement with Verde Bioresins, Inc., its impending delisting from Nasdaq, and a board decision to pursue an orderly winding down and dissolution of the company.

Nxu, Inc. announced its securities will be delisted from Nasdaq after failing to meet the minimum bid price requirement, despite a reverse stock split, and the company does not intend to appeal the decision.

Nxu, Inc. received a delisting notice from Nasdaq after failing to meet the minimum bid price requirement, despite a reverse stock split, and is appealing the decision.

Nxu, Inc. will implement a 1-for-20 reverse stock split of its Class A common stock, effective March 31, 2025.

Nxu, Inc. will implement a 1-for-20 reverse stock split effective March 31, 2025, to meet Nasdaq's minimum bid price requirements.

Nxu, Inc. stockholders voted to approve the merger with Verde Bioresins, along with amendments to the company's certificate of incorporation, at a special meeting held on February 11, 2025.

Nxu Inc. announces its Q1 2025 financial results, highlighting minimal revenue, ongoing losses, and efforts to finalize its merger with Verde Bioresins while addressing Nasdaq listing requirements.

Nxu Inc. reported its Q3 2024 financial results, highlighting a strategic shift towards a merger with Verde Bioresins, while facing ongoing financial challenges.

Nxu Inc. announced its Q2 2024 results, highlighting a strategic review, cost reductions, and a shift in focus towards exploring strategic alternatives.

Nxu Inc. reported a net loss of $6.5 million for the first quarter of 2024, while focusing on the production and deployment of its megawatt charging stations.

Nxu Inc. files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and other corporate governance matters.

Nxu Inc.'s 10-K filing reveals substantial losses and going concern doubts, even as it pursues a merger with Verde Bioresins to bolster its financial standing.

Nxu, Inc. has filed an amendment to its annual report on Form 10-K, providing previously omitted information regarding directors, executive compensation, and corporate governance.

Nxu Inc.'s 2023 annual report reveals a strategic pivot towards charging infrastructure development, alongside ongoing losses and a need for additional capital.

Annie Pratt, President of Nxu, Inc., files an amended Form 4/A to correct previously reported transactions involving Class A Common Stock and Restricted Stock Units (RSUs), primarily related to 'sell to cover' transactions for tax withholding obligations.

Annie Pratt, President of Nxu, Inc., reports acquisition and disposal of Class A Common Stock in a series of transactions between March 5th and March 11th, 2025.

Annie Pratt, a director and President of Nxu, Inc., disposed of 35,505 shares of Class A Common Stock on March 3, 2025, to cover tax obligations.

Annie Pratt, a director and President of Nxu, Inc., disposed of 22,896 shares of Class A Common Stock on February 27, 2025, to cover tax obligations.

Director Jessica Billingsley of Nxu, Inc. reports the acquisition of restricted stock units and the sale of common stock in recent transactions.

Nxu Inc. President Annie Pratt reported the disposal and acquisition of Class A Common Stock on January 22nd and 24th, 2025.

Nxu Inc. has entered into a Securities Purchase Agreement to raise $3 million through a private placement, involving shares, pre-funded warrants, and new warrants, to support its ongoing merger with Verde Bioresins.

Nxu, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) in compliance with Section 14(a) of the Securities Exchange Act of 1934.

Nxu Inc. files an amendment to its proxy statement to address quorum requirements, revise proposals for charter amendment and preferred stock authorization, and announce the adjourned date for its 2024 annual meeting.

Nxu, Inc. reminds stockholders to vote on proxy proposals before the adjourned Annual Meeting on July 15, 2024.

Nxu, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to Section 14(a) of the Securities Exchange Act of 1934.

Nxu, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to Section 14(a) of the Securities Exchange Act of 1934.

Nxu Inc. has filed an amendment to its S-1 registration statement, covering the resale of up to 114.5 million shares of Class A common stock by selling stockholders, as the company navigates a strategic merger with Verde Bioresins.

Nxu, Inc. has filed an S-1 registration statement for the resale of up to 114,503,816 shares of Class A common stock by selling stockholders, as the company progresses towards a merger with Verde Bioresins, Inc.

L1 Capital Global Opportunities Master Fund, Ltd. has significantly reduced its beneficial ownership in Nxu Inc. Class A Common Stock to 286 shares, representing 0.01% of the outstanding class.

L1 Capital Global Opportunities Master Fund, Ltd. has filed an amended Schedule 13G, disclosing a 6.37% beneficial ownership in Nxu Inc. through 1,500,000 Class A Warrants, a change from its previously reported common stock holdings.

L1 Capital Global Opportunities Master Fund, Ltd. has reported a 9.99% beneficial ownership stake in Nxu Inc.'s Class A Common Stock, totaling 2,582,000 shares, as of December 27, 2024.